These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7219078)

  • 1. Antilipidemic activity of 4-oxo-functionalized ethyl 6-chlorochroman-2-carboxylate analogs and a related tricyclic lactone in three rat models.
    Cavestri RC; Minatelli JA; Baldwin JR; Loh W; Feller DR; Newman HA; Sober CL; Witiak DT
    Lipids; 1981 Jan; 16(1):30-6. PubMed ID: 7219078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: II. High sucrose-fed animals.
    Mukhopadhyay A; Patel ST; O'Brien M; Kokrady SS; Newman HA; Witiak DT; Lanese RR; Rice JC; Feller DR
    Lipids; 1983 Jan; 18(1):59-67. PubMed ID: 6835036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of ethyl 6-substituted-chroman- and -chromone-2-carboxylates. A comparative structure-activity study employing the 6-phenyl and phenoxy analogs in the triton hyperlipidemic rat model.
    Witiak DT; Heilman WP; Sankarappa SK; Cavestri RC; Newman HA
    J Med Chem; 1975 Sep; 18(9):935-42. PubMed ID: 1159716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate.
    Witiak DT; Newman HA; Poochikian GK; Fogt SW; Baldwin JR; Sober CL; Feller DR
    J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals.
    O'Brien M; Patel ST; Mukhopadhyay A; Newman HA; Feller DR; Kokrady SS; Witiak DT; Lanese RR; Rice JC
    Lipids; 1981 Dec; 16(12):903-11. PubMed ID: 7329211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone.
    Witiak DT; Kuwano E; Feller DR; Baldwin JR; Newman HA; Sankrappa SK
    J Med Chem; 1976 Oct; 19(10):1214-20. PubMed ID: 994152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one.
    Witiak DT; Cavestri RC; Newman HA; Baldwin JR; Sober CL; Feller DR
    J Med Chem; 1978 Dec; 21(12):1198-202. PubMed ID: 722728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antilipidemic effects of various ethyl 5-substituted benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a triton hyperlipidemic rat model.
    Witiak DT; Newman HA; Poochikian GK; Loh W; Sankarappa SK
    Lipids; 1976 May; 11(5):384-91. PubMed ID: 1271976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model.
    Newman HA; Heilman WP; Witiak DT
    Lipids; 1973 Jul; 8(7):378-84. PubMed ID: 4724016
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of hypocholesterolemic activity for cyclic analogs of clofibrate in normolipemic rats.
    Goldberg AP; Mellon WS; Witiak DT; Feller DR
    Atherosclerosis; 1977 May; 27(1):15-25. PubMed ID: 857813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of cis-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-1-ones. Tricyclic analogues related to the antilipidemic drug clofibrate.
    Witiak DT; Loh W; Feller DR; Baldwin JR; Newman HA; Sober CL; Cavestri RC
    J Med Chem; 1979 Jun; 22(6):699-705. PubMed ID: 110933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
    Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in triton WR-1339-induced hyperlipidemia.
    Kuroda M; Tanzawa K; Tsujita Y; Endo A
    Biochim Biophys Acta; 1977 Oct; 489(1):119-25. PubMed ID: 911870
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
    Krause BR; Newton RS
    Atherosclerosis; 1995 Oct; 117(2):237-44. PubMed ID: 8801869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9-Chloro-2,3-dihydro-5H-1,4-dioxepino(6,5-b)benzofuran, a novel antilipidemic agent structurally related to clofibrate.
    Witiak DT; Poochikian GK; Feller DR; Kenfield NA; Newman HA
    J Med Chem; 1975 Oct; 18(10):992-6. PubMed ID: 1159693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism.
    Lewis NJ; Feller DR; Poochikian GK; Witiak DT
    J Med Chem; 1974 Jan; 17(1):41-5. PubMed ID: 4808468
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypolipidemic activity of Phellinus rimosus against triton WR-1339 and high cholesterol diet induced hyperlipidemic rats.
    Rony KA; Ajith TA; Nima N; Janardhanan KK
    Environ Toxicol Pharmacol; 2014 Mar; 37(2):482-92. PubMed ID: 24561532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
    Jiang C; Wang Q; Wei Y; Yao N; Wu Z; Ma Y; Lin Z; Zhao M; Che C; Yao X; Zhang J; Yin Z
    J Ethnopharmacol; 2015 Dec; 176():17-26. PubMed ID: 26477373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activities of 3-hydroxyl-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and the rate of mevalonic acid, squalene, sterol and fatty acid biosynthesis from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: effects of Triton WR 1339, starvation and cholesterol diet].
    Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
    Biokhimiia; 1981 Feb; 46(2):296-305. PubMed ID: 6113854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on screening for cholesterol-lowering agents using phenyl- and chromane substituted compounds (author's transl)].
    Yoshida K; Nakamura H
    Hokkaido Igaku Zasshi; 1976 Nov; 51(6):513-8. PubMed ID: 1035574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.